Aptorum Group logo

Aptorum Group Share Price (NASDAQ: APM)

$1.98

-0.23

(-10.41%)

Last updated on

Check the interactive Aptorum Group Stock chart to analyse performance

Aptorum Group stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.94
    Today's High:$2.21

    Day's Volatility :12.22%

  • 52 Weeks Low:$0.46
    52 Weeks High:$7.49

    52 Weeks Volatility :93.86%

Aptorum Group Stock Returns

PeriodAptorum Group LtdIndex (Russel 2000)
3 Months
99.0%
0.0%
6 Months
123.09%
0.0%
1 Year
-34.32%
0.0%
3 Years
-86.28%
-4.7%

Aptorum Group Ltd Key Stats

Check Aptorum Group key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.21
Open
$2.21
Today's High
$2.21
Today's Low
$1.94
Market Capitalization
$15.8M
Today's Volume
$494.4K
52 Week High
$7.4899
52 Week Low
$0.46
Revenue TTM
$0.0
EBITDA
$-2.2M
Earnings Per Share (EPS)
$-0.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-30.62%

Stock Returns calculator for Aptorum Group Stock including INR - Dollar returns

The Aptorum Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aptorum Group investment value today

Current value as on today

₹71,505

Returns

₹28,495

(-28.5%)

Returns from Aptorum Group Stock

₹33,779 (-33.78%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Aptorum Group Stock

18.91%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Aptorum Group Shares from India has grown by 18.91% over the past 30 days, indicating increased transactional activity.

92%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Aptorum Group Stock from India on INDmoney has increased by 92% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Aptorum Group Ltd

  • Name

    Holdings %

  • Geode Capital Management, LLC

    0.52%

  • Morgan Stanley - Brokerage Accounts

    0.30%

  • Susquehanna International Group, LLP

    0.24%

  • Advisor Group Holdings, Inc.

    0.08%

  • UBS Group AG

    0.05%

  • Citigroup Inc

    0.01%

Analyst Recommendation on Aptorum Group Stock

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 6 Wall street analysts offering stock ratings for Aptorum Group(by analysts ranked 0 to 5 stars)

Aptorum Group Share Price Target

What analysts predicted

Upside of 3940.4%

Target:

$80.00

Current:

$1.98

Aptorum Group share price target is $80.00, a slight Upside of 3940.4% compared to current price of $1.98 as per analysts' prediction.

Aptorum Group Stock Insights

  • Price Movement

    In the last 7 days, APM stock has moved down by -24.6%
  • APM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 103.3%
  • APM vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 198.9%

Aptorum Group Technicals Summary

Sell

Neutral

Buy

Aptorum Group is currently in a neutral trading position according to technical analysis indicators.

Aptorum Group Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aptorum Group Ltd logo
45.26%
123.09%
-34.32%
-86.28%
-90.29%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Aptorum Group Ltd

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The company also develops SACT-COV19, a repurposed small molecule which is in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule which is in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule which is in preclinical trial for the treatment of gram+ve bacterial infections. In addition, it is developing NLS-1, which is in preclinical trial for the treatment of endometriosis; DLS-1+2, which is in preclinical trial to treat NSCLC with mutation; DLS-3, which is in preclinical trial to treat autoimmune disease; CLS-1, a macromolecule, which is in preclinical trial to treat obesity; and CLS-1 and CLS-3. Further, the company offers NativusWell DOI (NLS-2), a dietary supplement for women undergoing menopause; and provides management services. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Organization
Aptorum Group
Employees
1
CEO
Mr. Chung Yuen Huen
Industry
Health Technology

Key Management of Aptorum Group Ltd

NameTitle
Mr. Chung Yuen Huen
Founder, CEO & Executive Director
Mr. Kwok Kuen Wong
Head of Finance

Important FAQs about investing in APM Stock from India :

What is Aptorum Group share price today?

Aptorum Group share price today is $1.98 as on at the close of the market. Aptorum Group share today touched a day high of $2.21 and a low of $1.94.

What is the 52 week high and 52 week low for Aptorum Group share?

Aptorum Group share touched a 52 week high of $7.49 and a 52 week low of $0.46. Aptorum Group stock price today i.e. is closed at $1.98, lower by 73.56% versus the 52 week high.

How to invest in Aptorum Group Stock (APM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aptorum Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aptorum Group Shares that will get you 0.7576 shares as per Aptorum Group share price of $1.98 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aptorum Group Stock (APM) from India?

Indian investors can start investing in Aptorum Group (APM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Aptorum Group stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Aptorum Group share’s latest price of $1.98 as on August 30, 2025 at 1:29 am IST, you will get 5.0505 shares of Aptorum Group. Learn more about fractional shares .

What are the returns that Aptorum Group has given to Indian investors in the last 5 years?

Aptorum Group stock has given -90.29% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?